- Home
- ATYR vs ADV Comparison
ATYR vs ADV Comparison
Compare ATYR & ADV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATYR
- ADV
- Stock Information
- Founded
- ATYR 2005
- ADV 1987
- Country
- ATYR United States
- ADV United States
- Employees
- ATYR N/A
- ADV N/A
- Industry
- ATYR Biotechnology: Biological Products (No Diagnostic Substances)
- ADV Business Services
- Sector
- ATYR Health Care
- ADV Consumer Discretionary
- Exchange
- ATYR Nasdaq
- ADV Nasdaq
- Market Cap
- ATYR 535.0M
- ADV 586.7M
- IPO Year
- ATYR 2015
- ADV N/A
- Fundamental
- Price
- ATYR $5.63
- ADV $1.91
- Analyst Decision
- ATYR Strong Buy
- ADV Strong Buy
- Analyst Count
- ATYR 5
- ADV 1
- Target Price
- ATYR $23.25
- ADV $2.50
- AVG Volume (30 Days)
- ATYR 4.3M
- ADV 659.1K
- Earning Date
- ATYR 11-06-2025
- ADV 11-06-2025
- Dividend Yield
- ATYR N/A
- ADV N/A
- EPS Growth
- ATYR N/A
- ADV N/A
- EPS
- ATYR N/A
- ADV N/A
- Revenue
- ATYR N/A
- ADV $3,527,054,000.00
- Revenue This Year
- ATYR $478.72
- ADV N/A
- Revenue Next Year
- ATYR $1,899.26
- ADV N/A
- P/E Ratio
- ATYR N/A
- ADV N/A
- Revenue Growth
- ATYR N/A
- ADV N/A
- 52 Week Low
- ATYR $1.67
- ADV $1.04
- 52 Week High
- ATYR $7.29
- ADV $4.10
- Technical
- Relative Strength Index (RSI)
- ATYR 58.33
- ADV 57.44
- Support Level
- ATYR $5.08
- ADV $1.78
- Resistance Level
- ATYR $5.77
- ADV $1.93
- Average True Range (ATR)
- ATYR 0.42
- ADV 0.09
- MACD
- ATYR 0.02
- ADV -0.00
- Stochastic Oscillator
- ATYR 66.67
- ADV 78.43
About ATYR aTyr Pharma Inc. Common Stock
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.
About ADV Advantage Solutions Inc.
Advantage Solutions Inc is a omnichannel retail solutions agency in North America, uniquely positioned at the intersection of consumer-packaged goods (CPG) brands and retailers.